Dihydroartemisinin
- Generic Name
- Dihydroartemisinin
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C15H24O5
- CAS Number
- 71939-50-9
- Unique Ingredient Identifier
- 6A9O50735X
- Background
Artenimol is an artemisinin derivative and antimalarial agent used in the treatment of uncomplicated Plasmodium falciparum infections . It was first authorized for market by the European Medicines Agency in October 2011 in combination with Piperaquine as the product Eurartesim. Artemisinin combination therapy is highly effective against malaria and stongly r...
- Indication
For the treatment of uncomplicated Plasmodium falciparum infection in adults, children, and infants aged 6 months and up weighing over 5 kg . Used in combination with Piperaquine.
- Associated Conditions
- Malaria caused by Plasmodium falciparum
- Associated Therapies
- -
No news found
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath